Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide Therapy.
Li M, Chan DL, Tapia Rico G, Cehic G, Lawrence B, Wyld D, Pattison DA, Kong G, Hicks R, Michael M, Kiberu AD, Lim J, Clifton-Bligh R, Tsang V, Roach PJ, Leyden J, Diakos CI, Price TJ, Pavlakis N. Li M, et al. Among authors: price tj. Neuroendocrinology. 2023;113(3):281-288. doi: 10.1159/000526848. Epub 2022 Sep 1. Neuroendocrinology. 2023. PMID: 36049462 Free article. Review.
Correction: Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature.
Chan DL, Pavlakis N, Shapiro J, Price TJ, Karapetis CS, Tebbutt NC, Segelov E. Chan DL, et al. Among authors: price tj. PLoS One. 2015 Sep 25;10(9):e0138916. doi: 10.1371/journal.pone.0138916. eCollection 2015. PLoS One. 2015. PMID: 26406241 Free PMC article. No abstract available.
Prevention and management of carcinoid crises in patients with high-risk neuroendocrine tumours undergoing peptide receptor radionuclide therapy (PRRT): Literature review and case series from two Australian tertiary medical institutions.
Tapia Rico G, Li M, Pavlakis N, Cehic G, Price TJ. Tapia Rico G, et al. Among authors: price tj. Cancer Treat Rev. 2018 May;66:1-6. doi: 10.1016/j.ctrv.2018.03.002. Epub 2018 Mar 16. Cancer Treat Rev. 2018. PMID: 29602040 Review.
Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care.
Woodhouse B, Pattison S, Segelov E, Singh S, Parker K, Kong G, Macdonald W, Wyld D, Meyer-Rochow G, Pavlakis N, Conroy S, Gordon V, Koea J, Kramer N, Michael M, Wakelin K, Asif T, Lo D, Price T, Lawrence B; Commonwealth Neuroendocrine Tumour Collaboration (CommNETs). Woodhouse B, et al. J Clin Med. 2019 Sep 12;8(9):1455. doi: 10.3390/jcm8091455. J Clin Med. 2019. PMID: 31547431 Free PMC article.
Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention.
Guccione L, Gough K, Drosdowsky A, Fisher K, Price T, Pavlakis N, Khasraw M, Wyld D, Ransom D, Kong G, Rogers M, Leyden S, Leyden J, Michael M, Schofield P. Guccione L, et al. JMIR Res Protoc. 2019 Dec 3;8(12):e14361. doi: 10.2196/14361. JMIR Res Protoc. 2019. PMID: 31793892 Free PMC article.
411 results